Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 14, 2016; 22(22): 5285-5292
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5285
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5285
Figure 1 Flow chart of studies screened and included in meta-analysis.
1Two studies included in two different sub-meta-analysis. SOF: Sofosbuvir; DCV: Daclatasvir; LDV: Ledipasvir; PEG-IFN: Polyethylene glycol interferon.
- Citation: Ampuero J, Reddy KR, Romero-Gomez M. Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options. World J Gastroenterol 2016; 22(22): 5285-5292
- URL: https://www.wjgnet.com/1007-9327/full/v22/i22/5285.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i22.5285